Allogene Therapeutics
ALLO
ALLO
180 hedge funds and large institutions have $835M invested in Allogene Therapeutics in 2022 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 72 increasing their positions, 45 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 177 → 180 (+3)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
35% less capital invested
Capital invested by funds: $1.28B → $835M (-$445M)
Holders
180
Holding in Top 10
2
Calls
$1.24M
Puts
$764K
Top Buyers
| 1 | +$36.1M | |
| 2 | +$11.9M | |
| 3 | +$10.6M | |
| 4 |
Renaissance Technologies
New York
|
+$10.2M |
| 5 |
Two Sigma Investments
New York
|
+$7.96M |
Top Sellers
| 1 | -$39.5M | |
| 2 | -$19.4M | |
| 3 | -$14.2M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$10.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.83M |